Preparation, Characterization, and in vivo Evaluation of NK4-Conjugated Hydroxycamptothecin-Loaded Liposomes

References

• Song P, Cai Y, Tang H, Li C, Huang J. The clinical management of hepatocellular carcinoma worldwide: a concise review and comparison of current guidelines from 2001 to 2017. Biosci Trends. 2017;11(4):389–398. doi:10.5582/bst.2017.0120228904327
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.v68.630207593
   PubMed Web of Science ®Google Scholar
• Galle PR, Forner A, Llovet JM, et al. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.01929628281
   PubMed Web of Science ®Google Scholar
• Wang TE, Ding Y, Yang YF, et al. Synergistic antitumor effects of triptolide plus 10-hydroxycamptothecin on bladder cancer. Biomed Pharmacother. 2019;115:108899. doi:10.1016/j.biopha.2019.10889931063955
   PubMed Web of Science ®Google Scholar
• Xing H, Luo X, Li Y, et al. Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism. Pharm Biol. 2020;58(1):152–156. doi:10.1080/13880209.2020.171755031990625
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen C, Xiao Y, Zhang X, Chen Y. Liposomes encapsulating 10-hydroxycamptothecin-cyclodextrin complexes and their in vitro anti-tumor activities. J Nanosci Nanotechnol. 2015;15(5):3786–3795. doi:10.1166/jnn.2015.949526505006
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu X, Mi Y, Li H, Hou W. Engineering of (10-hydroxycamptothecin intercalated layered double hydroxide)@liposome nanocomposites with excellent water dispersity. J Phys Chem Solids. 2017;108:125–132. doi:10.1016/j.jpcs.2017.04.018
   Web of Science ®Google Scholar
• Zhu HM, Gu JH, Xie Y, et al. Hydroxycamptothecin liposomes based on thermal and magnetic dual-responsive system: preparation, in vitro and in vivo antitumor activity, microdialysis-based tumor pharmacokinetics. J Drug Target. 2017;26(1):1–12. doi:10.1080/1061186X.2017.133919628581825
   PubMedGoogle Scholar
• Yang J, Ni B, Liu J, Zhu L, Zhou W. Application of liposome-encapsulated hydroxycamptothecin in the prevention of epidural scar formation in New Zealand white rabbits. Spine J. 2011;11(3):218–223. doi:10.1016/j.spinee.2011.01.02821377604
   PubMed Web of Science ®Google Scholar
• Brannon Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2012;64:206–212. doi:10.1016/j.addr.2012.09.033
   Web of Science ®Google Scholar
• Fang YP, Chuang CH, Wu YJ, et al. SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study. Int J Nanomedicine. 2018;13:2789–2802. doi:10.2147/IJN.S15842629785106
   PubMed Web of Science ®Google Scholar
• Shi LL, Tang C, Yin CH. Glycyrrhizin-modified o-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma. Biomaterials. 2012;33(30):7594–7604. doi:10.1016/j.biomaterials.2012.06.07222796165
   PubMed Web of Science ®Google Scholar
• Chen JD, Jiang H, Wu Y, et al. A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation. Drug Des Devel Ther. 2015;9:2265–2275. doi:10.2147/DDDT.S81722
   PubMed Web of Science ®Google Scholar
• Xia Y, Zhong JY, Zhao MQ, et al. Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma. Drug Deliv. 2019;26(1):1–11. doi:10.1080/10717544.2018.155635931928356
   PubMed Web of Science ®Google Scholar
• Shi C, Gao F, Gao X, Liu Y. A novel anti-VEGF165 monoclonal antibody-conjugated liposomal nanocarrier system: physical characterization and cellular uptake evaluation in vitro and in vivo. Biomed Pharmacother. 2015;69:191–200. doi:10.1016/j.biopha.2014.11.02525661357
   PubMed Web of Science ®Google Scholar
• Liu D, Xing J, Xiong F, Yang F, Gu N. Preparation and in vivo safety evaluations of antileukemic homoharringtonine-loaded PEGylated liposomes. Drug Dev Ind Pharm. 2017;43(4):652–660. doi:10.1080/03639045.2016.127567028005445
   PubMed Web of Science ®Google Scholar
• Ghanaatgar-Kasbi S, Khorrami S, Avan A, et al. Targeting the c-MET/HGF signaling pathway in pancreatic ductal adenocarcinoma. Curr Pharm Des. 2019;24(39):4619–4625. doi:10.2174/1381612825666190110145855
   Web of Science ®Google Scholar
• Ariyawutyakorn W, Saichaemchan S, Varella-Garcia M. Understanding and targeting MET signaling in solid tumors - are we there yet? J Cancer. 2016;7(6):633–649. doi:10.7150/jca.1266327076844
   PubMed Web of Science ®Google Scholar
• Guo JR, Li W, Wu Y, et al. Hepatocyte growth factor promotes proliferation, invasion, and metastasis of myeloid leukemia cells through PI3K-AKT and MAPK/ERK signaling pathway. Am J Transl Res. 2016;8:3630–3644.27725846
   PubMed Web of Science ®Google Scholar
• Hao NB, Tang B, Wang GZ, et al. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis. Cancer Lett. 2015;361(1):57–66. doi:10.1016/j.canlet.2015.02.04325727320
   PubMed Web of Science ®Google Scholar
• Xie R, Li QP, Ge XX, et al. NK4 suppresses cholangiocarcinoma angiogenesis and invasion through targeting HIF-1α pathway. Int J Clin Exp Med. 2017;10:2345–2352.
   Web of Science ®Google Scholar
• Cai C, Hou LL, Zhang JS, et al. The inhibitory effect of mesenchymal stem cells with rAd-NK4 on liver cancer. Appl Biochem Biotechnol. 2017;183(1):444–459. doi:10.1007/s12010-017-2456-x28353041
   PubMed Web of Science ®Google Scholar
• Deng XB, Xiao L, Wu Y, et al. Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy. Int J Cancer. 2015;137(2):481–490. doi:10.1002/ijc.v137.225501304
   PubMed Web of Science ®Google Scholar
• Zhu Y, Cheng M, Yang Z, et al. Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts. Drug Des Devel Ther. 2014;8:2449–2462. doi:10.2147/DDDT.S71466
   PubMed Web of Science ®Google Scholar
• Gao Z, Zheng X, Shen R, et al. NK4 growth inhibition of human Raji lymphoma xenografts by competitive interrupting HGF/Met signal pathway. Chin J Pathol. 2014;43:551–555.
   Google Scholar
• Wang DD, Saga Y, Sato N, et al. The hepatocyte growth factor antagonist NK4 inhibits indoleamine-2, 3-dioxygenase expression via the c-Met-phosphatidylinositol 3-kinase-AKT signaling pathway. Int J Oncol. 2016;48(6):2303–2309. doi:10.3892/ijo.2016.348627082119
   PubMed Web of Science ®Google Scholar
• Lu RM, Chang YL, Chen MS, et al. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery. Biomaterials. 2011;32(12):3265–3274. doi:10.1016/j.biomaterials.2010.12.06121306768
   PubMed Web of Science ®Google Scholar
• Ye TT, Wu Y, Shang L, Deng X, Wang S. Improved lymphatic targeting: effect and mechanism of synthetic borneol on lymph node uptake of 7-ethyl-10-hydroxycamptothecin nanoliposomes following subcutaneous administration. Drug Deliv. 2018;25(1):1461–1471. doi:10.1080/10717544.2018.148297329902927
   PubMed Web of Science ®Google Scholar
• Zhou T, Tang X, Zhang W, Feng J, Wu W. Preparation and in vitro and in vivo evaluations of 10-hydroxycamptothecin liposomes modified with stearyl glycyrrhetinate. Drug Deliv. 2019;26(1):673–679. doi:10.1080/10717544.2019.163642231266376
   PubMed Web of Science ®Google Scholar
• Chen J, Chen YC, Cheng Y, Gao Y. Glycyrrhetinic acid liposomes containing mannose-diester lauric diacid-cholesterol conjugate synthesized by lipase-catalytic acylation for liver-specific delivery. Molecules. 2017;22(10):1598–1617. doi:10.3390/molecules22101598
   PubMed Web of Science ®Google Scholar
• Nayak D, Boxi A, Ashe S, Thathapudi NC, Nayak B. Stavudine loaded gelatin liposomes for HIV therapy: preparation, characterization and in vitro cytotoxic evaluation. Mater Sci Eng C. 2017;73:406–416. doi:10.1016/j.msec.2016.12.073
   PubMed Web of Science ®Google Scholar
• Li Y, Liu R, Yang J, et al. Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior. Biomaterials. 2015;41:1–14. doi:10.1016/j.biomaterials.2014.11.01025522960
   PubMed Web of Science ®Google Scholar